Tenet Healthcare Corporation

THC Healthcare Medical Care Facilities

In the quarter to June 2026, revenue grew 14.6%, EPS grew 213.0%, free cash flow fell 43.9% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years.

268.62 6.51 −2.37%
Market cap
$22.2B
P/E
10.3×
Fwd P/E
6.4×
Dividend yield
—
F-score
7/9
Altman Z
1.91
Beneish M
−2.67
Dividend safety
57/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 15.72 0.00 10.54 9.58 12.76 12.63 3.88 12.73
Piotroski F-Score
5 3 6 5 6 7 4 9 7 7
P/S ratio
0.08 0.08 0.10 0.21 0.24 0.45 0.27 0.38 0.59 0.84
Altman Z-Score
0.96 0.94 1.01 1.01 0.98 1.28 1.14 1.29 2.00 1.91
Altman Z″-Score (non-manufacturers)
0.48 0.36 0.43 0.36 0.83 1.11 0.95 1.26 2.75 2.29
P/FCF ratio
0.00 3.26 4.05 6.98 1.46 9.59 16.32 4.76 10.96 7.08
Beneish M-Score
(2.48) (2.89) (2.59) (2.64) (2.92) (2.48) (2.39) (2.69) (2.25) (2.67)
P/Operating CF
(5.22) 3.28 7.00 7.56 9.40 24.45 12.44 9.38 (36.96) 24.51
Dividend Safety Score
— — — — — — — — — 57
P/B ratio
1.41 2.98 2.55 9.00 4.48 4.25 2.13 2.48 2.10 2.98
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
0.82 0.83 0.88 1.00 0.99 1.13 1.01 1.05 1.08 1.32
EV/EBITDA
7.52 7.86 6.51 7.61 6.06 5.86 6.07 6.30 3.29 6.42
EV/Operating CF
28.80 13.28 15.41 14.94 5.13 14.04 17.97 9.06 10.94 7.97
EV/FCF
(50.69) 32.32 37.42 32.72 6.09 24.19 60.62 13.25 20.06 11.15
Quick Ratio
0.90 0.75 0.78 0.72 1.06 1.00 0.85 0.87 1.29 1.22
Current Ratio
1.30 1.29 1.20 1.21 1.47 1.38 1.34 1.51 1.78 1.76
Net Debt/EBITDA
6.80 7.07 5.80 5.98 4.60 3.53 4.43 4.04 1.49 2.34
Debt/Assets
61.76% 63.87% 66.16% 63.13% 57.99% 56.73% 55.53% 52.99% 45.52% 44.38%
Debt/Equity
14.10 27.71 21.58 33.76 16.78 7.62 6.13 4.81 2.26 2.19
Asset Turnover
0.81 0.80 0.80 0.81 0.70 0.71 0.70 0.74 0.72 0.73
Operating CF/Net income
(2.91) (1.70) 10.09 (5.73) 8.54 1.72 2.64 3.89 0.64 2.52
Capex/Depreciation
(0.98) (0.77) (0.73) (0.76) (0.60) (0.74) (0.87) (0.83) (1.10) (1.14)
Interest Coverage
1.27 1.08 1.63 1.56 1.98 3.11 2.62 2.79 7.21 4.27
ROE
(18.82%) (86.86%) 16.97% (38.26%) 58.08% 61.12% 18.21% 21.92% 71.61% 23.77%
ROA
(0.79%) (2.93%) 0.45% (0.94%) 1.58% 3.34% 1.50% 2.20% 11.18% 4.80%
ROIC
4.99% 4.68% 6.77% 6.44% 8.75% 11.70% 8.74% 9.29% 23.30% 13.45%
Return on Tangible Assets
(2.07%) (8.51%) 1.34% (2.77%) 4.44% 10.89% 5.16% 7.07% 33.97% 14.50%
Average Days of Receivables
53.97 49.88 52.14 54.38 55.66 51.89 56.02 51.72 44.77 43.93
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.38 0.38 0.40 0.38 0.38 0.39 0.43 0.41 0.42 0.42
Share Based Compensation of Revenue
0.35% 0.31% 0.25% 0.23% 0.25% 0.29% 0.29% 0.32% 0.32% 0.49%
Graham Net Nets
(12.00) (10.74) (9.76) (4.54) (4.54) (2.11) (3.57) (2.33) (1.26) (0.88)
Graham Number
0.00 0.00 12.85 0.00 27.58 60.75 44.57 64.45 209.66 153.11
Earnings Yield
(12.53%) (43.71%) 6.36% (5.86%) 9.49% 10.44% 7.84% 7.92% 25.77% 7.86%
Free Cash Flow Yield
(20.73%) 30.65% 24.68% 14.32% 68.38% 10.43% 6.13% 21.00% 9.12% 14.12%
Revenue per Share
197.55 190.66 179.35 178.72 167.98 182.39 179.32 202.32 213.36 236.38
Operating CF per Share
5.62 11.93 10.27 11.92 32.44 14.68 10.13 23.36 21.12 39.27
Capex per Share
(8.81) (7.03) (6.04) (6.48) (5.14) (6.16) (7.13) (7.39) (9.61) (11.20)
Free Cash Flow per Share
(3.19) 4.90 4.23 5.45 27.30 8.52 3.00 15.97 11.52 28.06
Cash per Share
7.21 6.07 4.03 2.53 23.29 22.13 8.02 12.08 31.15 31.98
Shareholders Equity per Share
10.89 5.36 6.73 4.23 8.92 19.23 23.00 30.67 60.06 66.74
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
10.89 5.36 6.73 4.23 8.92 19.23 23.00 30.67 60.06 66.74
Free Cash Flow
(317.00) 493.00 432.00 563.00 2,867.00 910.00 321.00 1,623.00 1,116.00 2,530.00
Working Capital
1,223.00 1,241.00 779.00 876.00 2,300.00 1,966.00 1,505.00 2,407.00 3,372.00 3,386.00
Capital Expenditures
(875.00) (707.00) (617.00) (670.00) (540.00) (658.00) (762.00) (751.00) (931.00) (1,010.00)
Net Current Asset Value
(18,362.00) (17,273.00) (17,086.00) (17,847.00) (19,022.00) (18,450.00) (18,716.00) (18,028.00) (15,434.00) (15,811.00)
EV/EBIT
12.89 14.32 9.87 11.99 8.78 7.67 8.34 8.57 3.76 8.04
Capex to Sales
0.04 0.04 0.03 0.04 0.03 0.03 0.04 0.04 0.05 0.05
Price to Operating Income
1.23 1.45 1.07 2.56 2.11 3.04 2.24 3.08 2.05 5.11
Other line items
Depreciation/Fixed assets
0.11 0.13 0.12 0.13 0.13 0.14 0.14 0.14 0.14 0.14
Cash ROIC
(1.86%) 3.06% 2.71% 3.64% 15.01% 4.54% 1.74% 8.39% 5.07% 11.46%
Accounts Receivable Turnover
6.99 6.95 6.99 6.88 6.48 7.14 6.71 7.02 7.59 8.36
Accounts Payable Turnover
9.19 9.87 9.77 9.75 9.46 9.74 8.64 8.75 9.21 9.41
Inventory Turnover
39.22 40.19 39.18 38.23 33.63 32.46 30.71 31.22 32.89 35.98
Average Days of Payables
38.96 34.70 37.86 37.38 38.65 38.87 45.30 40.35 37.94 39.76
Days of Inventory on Hand
9.56 8.54 9.57 9.63 11.78 11.48 12.20 11.78 10.15 10.17
Average Receivables
2,806.00 2,761.00 2,618.50 2,684.50 2,721.50 2,730.00 2,856.50 2,928.50 2,725.00 2,550.50
Average Payables
1,354.50 1,252.00 1,191.00 1,205.50 1,205.50 1,253.50 1,402.00 1,456.00 1,351.00 1,327.00
Average Inventory
317.50 307.50 297.00 307.50 339.00 376.00 394.50 408.00 378.50 347.00
Average Assets
24,191.50 24,043.00 22,897.00 22,887.00 25,235.50 27,342.50 27,367.50 27,734.00 28,624.00 29,306.50
Average Common Equity
1,020.00 810.50 613.00 562.00 687.00 1,495.50 2,256.50 2,788.00 4,468.50 5,918.50

Fold the line items

Columns are period end dates